Pregabalin through the skin with ultrasound and calf stretching for knee osteoarthritis nerve pain
Tests pregabalin gel with ultrasound plus calf stretching for nerve pain in knee osteoarthritis.
Key facts
- Who runs it
- University of Faisalabad
- Where
- Pakistan1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Pregabalin Phonophoresis and MET for Knee Osteoarthritis
- Status
- Recruiting
- People taking part
- 35 people, planned
- Started
- 1 Jan 2026
- Planned end
- 19 Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Pregabalin-Encapsulated Hydrogel Phonophoresis
- Gastrocnemius Muscle Energy Technique (Post-Isometric Relaxation)
- Aqua Gel Phonophoresis
- Record updated
- 20 May 2026
Who can take part
The trial is looking for adults with Grade III knee osteoarthritis who also have nerve-type pain (burning, tingling or electric shock feelings).
- Age
- The criteria say 40 to 70 years. The age fields of the record say 40 to 60 Years.
- Sex
- Men and women can join.
- Disease stage
- Grade III knee osteoarthritis on the Kellgren-Lawrence scale, shown on an X-ray from the past 12 months or a new one. One or both knees may be affected.
- Earlier treatment
- No knee injection (corticosteroid or hyaluronic acid) in the last 3 months. No past partial or total knee replacement.
- Biomarker or test result
- A score of 4 or more on the DN-4 nerve pain questionnaire.
- Main reasons for not taking part
- Nerve damage from diabetes
- Metal implants, knee replacement, pacemaker or other electronic implant
- Grade I, II or IV knee osteoarthritis, or rheumatoid, psoriatic or gouty arthritis of the knee
- Allergy to pregabalin, gabapentin or the gel
- Pregnant or breastfeeding women
Show the full registry criteria (22)Hide the full registry criteria
Who can take part
- Diagnosed Grade III knee osteoarthritis confirmed by Kellgren-Lawrence grading scale (radiograph within past 12 months or newly obtained)
- Neuropathic pain component confirmed by DN-4 questionnaire (score ≥4)
- Age between 40 and 70 years inclusive
- Both male and female participants
- Unilateral or bilateral knee involvement (if bilateral, the more symptomatic knee selected for assessment and treatment)
- Willing and able to provide written informed consent
- Available to attend 4 sessions per week for 4 consecutive weeks (total 16 sessions)
- Able to understand and follow verbal instructions (for MET)
Who cannot take part
- Metal implants (including knee replacement), pacemaker, or other electronic implant (contraindications for ultrasound)
- Received intra-articular knee injection (corticosteroid or hyaluronic acid) within the last 3 months
- Previous knee replacement surgery (partial or total)
- Concurrent participation in another interventional study
- Diabetic neuropathy (diagnosed or DN-4 score attributable to diabetes rather than knee OA)
- Active skin lesions, wounds, infections, or dermatitis on the knee or calf
- Known allergy or hypersensitivity to pregabalin, gabapentin, or any gel components
- Diagnosis of fibromyalgia, complex regional pain syndrome, or other centralized pain disorder that might confound neuropathic pain assessment
- Active malignancy or history of knee malignancy
- Deep vein thrombosis or thrombophlebitis in lower limb
- Grade I, II, or IV knee osteoarthritis (Kellgren-Lawrence)
- Aseptic arthritis of knee (rheumatoid, psoriatic, gouty)
- Any lower extremity deformity (genu varum >15°, genu valgum >15°, fixed flexion deformity >15°)
- Pregnant or lactating women (ultrasound safety in pregnancy not established for non-obstetric use)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Knee osteoarthritis
This trial is currently available in Pakistan.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Knee osteoarthritis (OA) is a common condition causing pain, stiffness, and difficulty walking. Many patients with advanced (Grade III) knee OA also experience neuropathic pain - burning, tingling, or electric shock sensations - which is harder to treat with standard physiotherapy. Oral pregabalin works for neuropathic pain but causes side effects like dizziness and drowsiness. This study tests whether delivering pregabalin through the skin using ultrasound (phonophoresis), combined with calf muscle stretching (Muscle Energy Technique), can reduce nerve pain and improve walking better than ultrasound alone.
The 2 groups in the trial
- Group A: Pregabalin Phonophoresis + Gastrocnemius METTreatment being tested
Participants assigned to Group A receive pregabalin-encapsulated hydrogel phonophoresis followed by gastrocnemius muscle energy technique (post-isometric relaxation). Protocol: Hot pack (10 min), phonophoresis with pregabalin hydrogel (1 MHz, 1 W/cm², continuous, 5 min, circular application over knee), MET for gastrocnemius (7-10 sec isometric contraction followed by 10 sec stretch, repeated 4-5 times). Four sessions per week for four weeks (total 16 sessions).
Treatment: Pregabalin-Encapsulated Hydrogel Phonophoresis and Gastrocnemius Muscle Energy Technique (Post-Isometric Relaxation)
- Group B: Aqua Gel Phonophoresis + Gastrocnemius METExisting treatment, for comparison
Participants assigned to Group B receive aqua gel (non-medicated ultrasound gel) phonophoresis followed by gastrocnemius muscle energy technique (post-isometric relaxation). Protocol: Hot pack (10 min), phonophoresis with aqua gel (1 MHz, 1 W/cm², continuous, 5 min, circular application over knee), MET for gastrocnemius (7-10 sec isometric contraction followed by 10 sec stretch, repeated 4-5 times). Four sessions per week for four weeks (total 16 sessions).
Treatment: Gastrocnemius Muscle Energy Technique (Post-Isometric Relaxation) and Aqua Gel Phonophoresis
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluating the Combined Efficacy of Pregabalin-Encapsulated Hydrogel Phonophoresis Along With Gastrocnemius Muscle Energy Technique on Neuropathic Pain and Mobility in Grade III Knee Osteoarthritis
- Plain-language title
- Pregabalin through the skin with ultrasound and calf stretching for knee osteoarthritis nerve painGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT07598474, who can take part
- Record updated
- 20 May 2026